N Stahnke
Overview
Explore the profile of N Stahnke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stahnke N, Liebscher V, Staubach C, Ziller M
Prev Vet Med
. 2013 Sep;
112(3-4):355-69.
PMID: 24008002
The analysis of epidemiological field data from monitoring and surveillance systems (MOSSs) in wild animals is of great importance in order to evaluate the performance of such systems. By parameter...
2.
Reinehr T, Bechtold-Dalla Pozza S, Bettendorf M, Doerr H, Gohlke B, Hauffa B, et al.
Exp Clin Endocrinol Diabetes
. 2011 Oct;
119(9):544-8.
PMID: 22006181
Background: We hypothesized that overweight children with growth hormone deficiency (GHD) demonstrate a lower response to growth hormone (GH) as a result of a misclassification since obesity is associated with...
3.
Mehls O, Lindberg A, Bettendorf M, Doerr H, Hauffa B, Kaspers S, et al.
Horm Res
. 2009 Aug;
72(2):106-13.
PMID: 19690428
Background/aims: We investigated whether genetic or maternal/environmental risk factors for being born small for gestational age (SGA), e.g. Silver-Russell syndrome, congenital heart defects, infections of mothers or smoking during pregnancy,...
4.
Ranke M, Partsch C, Lindberg A, Dorr H, Bettendorf M, Hauffa B, et al.
Eur J Endocrinol
. 2002 Nov;
147(5):625-33.
PMID: 12444894
Objectives: We aimed to evaluate the factors influencing true adult height (HT) after long-term (from 1987 to 2000) GH treatment in Ullrich-Turner syndrome (UTS) based on modalities conceived in the...
5.
Stahnke N, Keller E, Landy H
J Pediatr Endocrinol Metab
. 2002 Mar;
15(2):129-38.
PMID: 11874177
The objective of this study was to find out whether moderate doses of growth hormone (GH) in combination with oxandrolone (Ox) and late initiation of puberty could improve adult height...
6.
Flitsch J, Ludecke D, Stahnke N, Wiebel J, Saeger W
Pituitary
. 2000 Nov;
2(4):261-7.
PMID: 11081147
The management of pituitary macroadenomas which lead to gigantism may require multiple therapeutical approaches, including medical treatment, surgery, and radiation therapy. Transsphenoidal surgery (TSS) during early childhood that achieves total...
7.
Stahnke N, Stubbe P, Keller E
Horm Res
. 1992 Jan;
37 Suppl 2:37-46.
PMID: 1490666
91 girls with Turner syndrome (TS) with a mean chronological age (CA) and bone age (BA) of 10.3 +/- 2.3 and 8.9 +/- 1.9 years, respectively, were randomly assigned to...
8.
Stubbe P, FRASIER S, Stahnke N, Cacciari E, Job J, Preece M, et al.
Horm Res
. 1992 Jan;
37 Suppl 2:28-36.
PMID: 1490665
In five clinical studies performed in Austria, France, the FRG, Italy, Switzerland, the UK and the USA, 304 growth hormone (GH)-deficient children were treated with recombinant human GH (rhGH) of...
9.
Stahnke N
Horm Res
. 1992 Jan;
38 Suppl 1:56-62.
PMID: 1295814
Since 1988 the number of growth hormone (GH)-treated patients has markedly increased worldwide. To date, leukemia has been observed in 31 patients during or following GH therapy and related malignancies...
10.